| Patent application number | Description | Published |
|---|
| 20090087411 | Long-acting interferons and derivatives thereof and methods thereof - A polypeptide and polynucleotides encoding same comprising carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an IFN protein are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 04-02-2009 |
| 20090270489 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME - A polypeptide and polynucleotides encoding same comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a peptide-of-interest are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 10-29-2009 |
| 20090275084 | LONG-ACTING EPO POLYPEPTIDES AND DERIVATIVES THEREOF AND METHODS THEREOF - A polypeptide and polynucleotides encoding same comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an EPO peptide are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 11-05-2009 |
| 20090286733 | LONG-ACTING VETERINARY POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - A polypeptide and polynucleotides comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a non-human peptide-of-interest are disclosed. Pharmaceutical compositions comprising the non-human polypeptides and polynucleotides of the invention and methods of using both human and non-human polypeptides and polynucleotides are also disclosed. | 11-19-2009 |
| 20090312254 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME - A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a cytokine and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a cytokine are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 12-17-2009 |
| 20100081614 | LONG-ACTING GROWTH HORMONE AND METHODS OF PRODUCING SAME - A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a growth hormone and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a growth hormone are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 04-01-2010 |
| Patent application number | Description | Published |
|---|
| 20080233076 | Process for stabilizing ascorbic acid compositions - The present invention relates to a process for inhibiting radical-induced damage to skin involving contacting the skin with a composition containing: a) ascorbic acid and/or a water soluble derivative thereof; b) at least one cinnamic acid derivative; c) water; d) at least one non-aqueous organic solvent; e) at least one pH adjusting agent; and, f) optionally, a surfactant, and wherein the pH of the composition is from about 4 to about 9. | 09-25-2008 |
| 20080299156 | SKIN CARE COMPOSITIONS CONTAINING A HIGH INTERNAL PHASE EMULSION - The present invention is directed to a skin care composition comprising (a) at least one high internal phase emollient-in-water emulsion; (b) at least one fatty compound, capable of forming a liquid crystal; (c) at least one thickening agent; (d) at least one active agent; and (e) water. Also disclosed is a method of treating skin with the above-disclosed skin care composition. | 12-04-2008 |
| 20080299157 | SKIN CARE COMPOSITIONS HAVING UNIQUE TEXTURE PROPERTIES - The present invention is directed to a skin care composition comprising (a) at least one high internal phase emollient-in-water emulsion; (b) at least one thickening agent; (c) at least one primary emulsifier chosen from a water-in-silicone emulsifier; (d) at least one non-emulsifying silicone elastomer; (e) at least one active agent; and (f) water. Also disclosed is a method of treating skin with the above-disclosed skin care composition. | 12-04-2008 |
| 20090053337 | COMPOSITION AND METHOD OF IMPROVING SKIN BARRIER FUNCTION OF COMPROMISED SKIN - A composition and method of improving skin barrier function of compromised skin by applying onto the compromised skin a composition containing: (a) a complex comprised of a metal-copper-antioxidant botanical pigment; (b) an extract of pinus pinaster bark; (c) an extract of pilewort; and (d) a carrier vehicle. | 02-26-2009 |
| 20100120645 | Fatty acid-free, foaming cosmetic composition and method of use - Disclosed are cosmetic compositions containing a disodium lauryl sulfosuccinate and a hydrophilically modified urethane. Also disclosed are methods for treating a keratinous substrate, such as skin or hair, by applying the cosmetic compositions to the keratinous substrate to, e.g., cleanse the keratinous substrate or deposit a cosmetically acceptable ingredient thereupon. | 05-13-2010 |
